RxDoctor Payments Data

Matthew Melin, MD

Vascular Surgery · Rochester, MNNPI 1730166992

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $123,884 of the $196,037 with a category attached, or 63.2%. Tactile Systems Technology Inc accounts for 75.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $109,268 and has fallen 99.9% since, to $63 in 2025. Among vascular surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$196,037in general payments, 2019–2025

Across 307 payments — averaging $638.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tactile Systems Technology Inc$149K
  • Medline Industries LP$19K
  • Aroa Biosurgery Incorporated$12K
  • Angiodynamics, Inc.$10K
  • Bioventus LLC$2K
  • Urgo Medical North America, LLC$1K
  • plus $3K from 14 others

What the payments were for

  • Consulting fees$21,66911%
  • Speaking & faculty fees$123,88463%
  • Travel & lodging$33,82817%
  • Food & beverage$6,6333%
  • Education$10,0165%
  • Gifts$70%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$196,037 in reported general payments places this provider in the 95th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$40,552
Medicare patients
228
Services billed
660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate97$2,440
Metronidazole38$932
Triamcinolone Acetonide21$128
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$103
Gabapentin11$88

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →